CONMED Corporation

CNMD • Medical - Devices

$49.32

▼ -0.10 (-0.20%)

Current price

EarningsLatest report: Jun 30, 2026

FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.

Market Cap

$1.49B

Growth

9.1%

Cash Flow

5/5

Trend

Stable

Evidence

Positive revenue growth · 6.3%Positive free cash flow · 4.86Consistent free cash flow · 5/5Manageable debt level · 0.81Healthy liquidity · 2.14

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$49.32

Change-0.20%

Shares Out30.12M

Market Cap$1.49B

Enterprise Value$2.28B

52W Range31.44 - 56.64

Beta0.93

P/E26.29

P/S1.08

P/B1.43

P/FCF11.05

EV/Sales1.66

Price$49.32

Change-0.20%

Shares Out30.12M

Market Cap$1.49B

Enterprise Value$2.28B

52W Range31.44 - 56.64

Beta0.93

P/E26.29

P/S1.08

P/B1.43

P/FCF11.05

EV/Sales1.66

EV/EBITDA10.48

EV/FCF16.97

Earnings Yield3.80%

FCF Yield9.05%

Dividend Yield0.81%

Gross Margin52.77%

Oper. Margin10.27%

Profit Margin3.42%

Debt/Eq0.81

Current Ratio2.14

Quick Ratio1.01

Revenue 5Y9.07%

Target$37.50

Target Upside-23.97%

Target Median$37.50

Target Range36.00 - 39.00

Volume849.83K

Avg Volume615.47K

EPS Surprise0.07

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

45/100

Financial Strength

Debt, cash, stability

73/100

Growth Potential

Revenue and expansion

82/100

Price Attractiveness

Cheap or expensive today

81/100

Why this score▼

Positive revenue growth · 6.3%Positive free cash flow · 4.86Consistent free cash flow · 5/5Manageable debt level · 0.81Healthy liquidity · 2.14

Analyst view

Analyst sentiment and price target

CNMD

Analyst sentiment

Based on 21 analyst votes · 2026-09-05

64/100

Neutral

Bullish

Hold

Bearish

Price Target

2026-07-31

Low

$36.00

Mean

$37.50

Median

$37.50

High

$39.00

Company Overview

IPO: 7/23/1987

Industry: Medical - Devices

P/B i: 1.43

Debt / Equity i: 0.81

Operating Margin: 10.27%

Net Margin: 3.42%

ROE i: -

ROIC: -

Financial Health

Score15 / 20

Debt / Equity: 0.81

Current Ratio: 2.14

Quick Ratio: 1.01

Status: Good

Insider Transactions

Recent executive and insider activity

Gallagher John E

Transaction: 07/15/2026

OTHER

Change

Price

Not reported

Filing

07/17/2026

Type

OTHER

Gallagher John E

Transaction: 07/15/2026

BUY

Change

+30,536

Price

$42.79

Filing

07/17/2026

Type

BUY

Gallagher John E

Transaction: 07/15/2026

BUY

Change

+35,054

Price

Not reported

Filing

07/17/2026

Type

BUY

Insider	Type	Change	Price	Transaction	Filing
Gallagher John E	OTHER	0	Not reported	07/15/2026	07/17/2026
Gallagher John E	BUY	+30,536	$42.79	07/15/2026	07/17/2026
Gallagher John E	BUY	+35,054	Not reported	07/15/2026	07/17/2026
Martin Celine Christine	OTHER	0	Not reported	07/01/2026	07/02/2026
Mirviss Jeffrey B.	OTHER	0	Not reported	07/01/2026	07/02/2026
Mirviss Jeffrey B.	BUY	+5,603	Not reported	07/01/2026	07/02/2026
Martin Celine Christine	BUY	+5,603	Not reported	07/01/2026	07/02/2026
Lockwood Kimberly	OTHER	+2,838	Not reported	06/01/2026	06/03/2026
Lockwood Kimberly	OTHER	+2,500	$79.95	06/01/2026	06/03/2026
Lockwood Kimberly	OTHER	0	Not reported	06/01/2026	06/03/2026
Beyer Pat	BUY	+28,145	Not reported	04/01/2026	04/02/2026
SHAGORY PETER K	BUY	+16,926	Not reported	03/02/2026	03/18/2026
Ferrell John D.	BUY	+16,926	Not reported	03/02/2026	03/18/2026
Foust Hollie K	BUY	+18,563	Not reported	03/02/2026	03/18/2026
Schabacker Matthew	BUY	+17,471	Not reported	03/02/2026	03/18/2026
Lalomia Brent	BUY	+17,198	Not reported	03/02/2026	03/18/2026
Lalomia Brent	SELL	-75	Not reported	03/06/2026	03/10/2026
Lalomia Brent	SELL	-26	$39.90	03/06/2026	03/10/2026
Beyer Pat	BUY	+28,800	Not reported	03/02/2026	03/04/2026
Beyer Pat	BUY	+68,258	$45.79	03/02/2026	03/04/2026

About the Company

CONMED Corporation

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.

Source - link

Peers

AHCO AZTA ESTA INMD KMTS NEOG NTLA NVCR SSII UFPT

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Canada Pension Plan Investment Board Buys Shares of 13,800 CONMED Corporation $CNMD

Canada Pension Plan Investment Board purchased a new position in CONMED Corporation (NYSE: CNMD) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 13,800 shares of the company's stock, valued at approximately $452,000. Other institutional investors also recently modified

Defense World

Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research

CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the Encore Boston Harbor in Everett, MA. Management will participate in a fireside chat on Wednesday, September 9th at 1:30 p.m. Eastern Time. A live audio webcast of the fireside chat will be accessible under the “Events” section of the company's investor relations website: https://www.conmed.com/en/inv.

Business Wire

CONMED Corporation: Organic Growth Is Masked By Divestitures

Conmed's headline growth appeared flat at $343 million in the last quarter, but organic growth actually increased by 6%, with the leading segment being the orthopedic surgery business. Growth was offset by the divestiture of the GI business; as a result, growth metrics look poor with a quant rating of F and below the sector growth. When I adjust for organic growth, impressive profitability, and a buyback story, Conmed stock looks highly undervalued below the sector multiple. and I am rating it a buy.

Seeking Alpha

CNMD Jumps 16% in a Month as Investors Assess Whether It Can Last

CNMD's 16% monthly rally is backed by stronger growth, margin gains and raised earnings guidance, but cash-flow and execution risks remain.

Zacks Investment Research

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-04-29	0.82	0.89	0.07
2026-01-28	1.32	1.43	0.11
2025-11-05	1.05	1.08	0.03
2025-07-30	1.13	1.15	0.02
2025-04-30	0.81	0.95	0.14
2025-02-05	1.2	1.34	0.14
2024-10-30	0.99	1.05	0.06
2024-07-31	0.91	0.98	0.07
2024-04-24	0.74	0.79	0.05
2024-01-31	1.11	1.06	-0.05
2023-10-25	0.83	0.9	0.07
2023-07-26	0.79	0.83	0.04